Gil Aharon
CIK: 0001811824
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Aug 13, 2026NRXS
Neuraxis, INC
Award(A)Direct43.9K shares at avg. $6.28$276K - Jul 29, 2026NRXS
Neuraxis, INC
Award(A)Direct2.2K shares- - Jul 29, 2026NRXS
Neuraxis, INC
Award(A)Indirect40.1K shares- - May 13, 2026DCTH
DELCATH SYSTEMS, INC.
Award(A)DirectStock Option (right to buy)
22.5K shares- - Apr 28, 2026NRXS
Neuraxis, INC
Award(A)Direct12.3K shares- - Apr 28, 2026NRXS
Neuraxis, INC
Award(A)Indirect221.9K shares- - Jan 22, 2026NRXS
Neuraxis, INC
Award(A)Direct21.6K shares at avg. $4.63$100K - Dec 23, 2025NRXS
Neuraxis, INC
Purchase(P)Indirect286.1K shares at avg. $3.52$1.0M - May 15, 2025DCTH
DELCATH SYSTEMS, INC.
Award(A)DirectStock Option (right to buy)
22.5K shares- - May 5, 2025DCTH
DELCATH SYSTEMS, INC.
In-the-Money(X)Indirect400K shares at avg. $10.00$4.0M - Dec 24, 2024DCTH
DELCATH SYSTEMS, INC.
Conversion(C)Indirect250K shares at avg. $10.00$2.5M - Dec 24, 2024DCTH
DELCATH SYSTEMS, INC.
Exercise(M)IndirectPre-funded Warrants
604K shares at avg. $9.99- - Oct 30, 2024DCTH
DELCATH SYSTEMS, INC.
Exercise(M)IndirectTranche B warrants to purchase F-4 Preferred Stock
500 shares at avg. $1000.00- - Oct 30, 2024DCTH
DELCATH SYSTEMS, INC.
Expiration (Short)(H)Indirect8% CONVERTIBLE NOTE
0 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 13, 2026 |  NRXS Neuraxis, INC | Award(A) | 43,930 | $6.28 | $275,880 | Direct |
| Jul 29, 2026 | NRXS Neuraxis, INC | Award(A) | 2,226 | - | $0 | Direct |
| Jul 29, 2026 | NRXS Neuraxis, INC | Award(A) | 40,068 | - | $0 | Indirect |
| May 13, 2026 |  DCTH DELCATH SYSTEMS, INC. | Award(A) Stock Option (right to buy) | 22,500 | - | - | Direct |
| Apr 28, 2026 | NRXS Neuraxis, INC | Award(A) | 12,304 | - | $0 | Direct |
| Apr 28, 2026 | NRXS Neuraxis, INC | Award(A) | 221,917 | - | $0 | Indirect |
| Jan 22, 2026 | NRXS Neuraxis, INC | Award(A) | 21,598 | $4.63 | $99,999 | Direct |
| Dec 23, 2025 | NRXS Neuraxis, INC | Purchase(P) | 286,138 | $3.52 | $1,007,206 | Indirect |
| May 15, 2025 | DCTH DELCATH SYSTEMS, INC. | Award(A) Stock Option (right to buy) | 22,500 | - | - | Direct |
| May 5, 2025 | DCTH DELCATH SYSTEMS, INC. | In-the-Money(X) | 400,000 | $10.00 | $4,000,000 | Indirect |
| Dec 24, 2024 | DCTH DELCATH SYSTEMS, INC. | Conversion(C) | 250,000 | $10.00 | $2,500,000 | Indirect |
| Dec 24, 2024 | DCTH DELCATH SYSTEMS, INC. | Exercise(M) Pre-funded Warrants | 603,954 | $9.99 | - | Indirect |
| Oct 30, 2024 | DCTH DELCATH SYSTEMS, INC. | Exercise(M) Tranche B warrants to purchase F-4 Preferred Stock | 500 | $1000.00 | - | Indirect |
| Oct 30, 2024 | DCTH DELCATH SYSTEMS, INC. | Expiration (Short)(H) 8% CONVERTIBLE NOTE | 0 | - | - | Indirect |
1-14 of 14 transactions
About Aharon Gil
Aharon Gil (SEC CIK 0001811824) files insider reports with the SEC as Director of Neuraxis, INC (NRXS) and Director of DELCATH SYSTEMS, INC. (DCTH).
Signal8 holds 10 ownership filings by Aharon Gil (1 Form 3, 9 Form 4), filed between Nov 1, 2024 and Aug 17, 2026. Those filings report 14 transactions, from Oct 30, 2024 to Aug 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Aharon Gil's filings is in TORONTO.
Recent filings by Aharon Gil
- Aug 13, 2026: Grant or award of NRXS shares (Form 4, code A).
- Jul 29, 2026: Grants or awards of NRXS shares (2 lines, Form 4, code A).
- May 13, 2026: Grant or award of DCTH derivative securities (Form 4, code A).
- Apr 28, 2026: Grants or awards of NRXS shares (2 lines, Form 4, code A).
- Jan 22, 2026: Grant or award of NRXS shares (Form 4, code A).
Other insiders filing for Neuraxis, INC (NRXS)
- Carrico Brian Allen, Chief Executive Officer
- Carrico Thomas Joeseph, CRO, CCO, CPO
- Henrichs Timothy Robert, Chief Financial Officer
- Blanchard Craig Thomas, Chief Commercial Officer
- Miranda Adrian, CMO, SVP Science & Tech
- Watkins Bradley Mitchell, Director